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Health conditions and health-policy innovations in Brazil: 
the way forward
Cesar G Victora, Mauricio L Barreto, Maria do Carmo Leal, Carlos A Monteiro, Maria Ines Schmidt, Jairnilson Paim, Francisco I Bastos, 
Celia Almeida, Ligia Bahia, Claudia Travassos, Michael Reichenheim, Fernando C Barros, and the Lancet Brazil Series Working Group*
Brazil is a large complex country that is undergoing rapid economic, social, and environmental change. In this Series 
of six articles, we have reported important improvements in health status and life expectancy, which can be ascribed 
largely to progress in social determinants of health and to implementation of a comprehensive national health system 
with strong social participation. Many challenges remain, however. Socioeconomic and regional disparities are still 
unacceptably large, reﬂ ecting the fact that much progress is still needed to improve basic living conditions for a large 
proportion of the population. New health problems arise as a result of urbanisation and social and environmental 
change, and some old health issues remain unabated. Administration of a complex, decentralised public-health 
system, in which a large share of services is contracted out to the private sector, together with many private insurance 
providers, inevitably causes conﬂ ict and contradiction. The challenge is ultimately political, and we conclude with a 
call for action that requires continuous engagement by Brazilian society as a whole in securing the right to health for 
all Brazilian people.
Introduction
“Brazil is not for beginners”, said Tom Jobim, one of the 
world’s greatest popular composers of the 20th century. 
Throughout this Series of articles,1–5 we have shown that 
this statement indeed seems to be the case. We have 
reported remarkable progress in some aspects of health 
and health care, in sharp contrast with stagnation or even 
deterioration in other indicators. One of the ten largest 
economies globally, Brazil still has a long way to go before 
reaching current levels of health in the world’s most 
aﬄ  uent nations.
Large countries tend to be complex and diﬃ  cult to 
administrate. With nearly 200 million inhabitants, striking 
regional diﬀ erences exist in Brazil, from the rich southeast 
and south (where life expectancy approaches that of rich 
countries),1 to the poorer north and northeast, and to the 
rapidly expanding frontier of the centre-west. In this Series 
of articles we have shown that, despite these deep divisions, 
the health of Brazilian people is improving.1–5 Over the 
past four decades, life expectancy at birth increased by 
more than 6 months per calendar year.1 Likewise, good 
progress is being made towards most of the Millennium 
Development Goals (MDGs; table 1). Indicators for MDG 1 
(poverty and child undernutrition) and MDG 4 (child 
survival) will most probably be met.2 Maternal mortality 
trends (MDG 5) have proven diﬃ  cult to measure with 
precision because of enhanced reporting; modelled 
estimates show an annual rate of decline of around 4%,7,8 
which will be insuﬃ  cient to reach the goal.2 With respect 
to infectious diseases (MDG 6), Brazil excels in control 
of vaccine-preventable diseases and HIV/AIDS, but 
other diseases—particularly dengue fever—have been 
unaﬀ ected by control eﬀ orts.3
Neither chronic diseases nor violence and injuries are 
part of the MDGs, although some researchers argue they 
should have been included.9,10 Brazil is making some 
progress in these areas. Mortality rates of non-
communicable diseases declined 20% between 1996 
and 2007, mainly due to reductions in cardiovascular and 
chronic respiratory diseases, in parallel with falling 
smoking rates. By contrast, hypertension, obesity, and 
diabetes have risen, and neuropsychiatric disorders are 
currently the major contributor to disease burden.4 Both 
homicide and traﬃ  c-related death rates started to fall 
slowly after reaching peak levels in the 1990s, but much 
still needs to be done to control these two epidemics;5 for 
example, homicide rates in Brazil remain several fold 
higher than in neighbouring countries such as Argentina, 
Chile, or Uruguay.11
Social, ethnic, and regional inequalities have plagued 
Brazilian society for centuries, which is not surprising 
since Brazil is one of the world’s leaders in terms of income 
inequalities. Nevertheless, in this Series we have provided 
evidence that socioeconomic and regional gaps in several 
health indicators are being narrowed progressively.
To place Brazil in perspective, table 2 shows time trends 
in key socioeconomic and health indicators in the seven 
Latin American countries with a population greater than 
15 million inhabitants. In 1960, Brazil was ranked ﬁ rst or 
second in terms of poverty, income concentration, rural 
population, illiteracy, and mortality. Income concentration 
in Brazil is especially high, with the Gini coeﬃ  cient 
reaching a peak of 0·64 in the late 1980s, when Brazil was 
the world’s most unequal country. Unlike any other 
country in table 2, Brazil has a huge land area and a major 
tropical disease burden at baseline. All countries showed 
progress in all indicators. Absolute and relative gaps 
between Brazil and the average value of the other six 
countries were reduced for all indicators, and for some of 
these (fertility and urbanisation) reversals took place. Gaps 
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in terms of life expectancy and under-5 mortality were 
small, except for a large reduction in the absolute gap in 
under-5 mortality, from 43·2 to 4·4 deaths per 
1000 livebirths between 1960 and 2009.
Trends in the health status of the Brazilian population 
over the past 50 years must be interpreted in terms of 
social determinants of health. Military dictatorship 
from 1964 to the late 1980s was characterised by rapid 
economic growth and increased income concentration, 
inadequate social protection with a fragmented health 
system, and little social participation in all sectors, 
including health. This situation did not preclude growth 
of a strong social movement advocating for reform of the 
health sector in the 1970s and 1980s. The return to 
democracy allowed creation of the Uniﬁ ed Health System 
(SUS) in the new 1988 constitution, with strong popular 
participation at all levels.1 Throughout this period, 
changes were seen in other determinants of health, 
including urbanisation (more than four in every ﬁ ve 
Brazilian people now live in cities), fertility (which 
dropped from more than six to fewer than two children 
per woman in 40 years), and education (primary education 
now being nearly universal).
From the mid-1990s, other major changes started to 
happen. Hyperinﬂ ation was controlled and economic 
stability—followed by moderate economic growth—was 
established. The Family Health Strategy (formerly called 
the Family Health Programme) expanded primary 
health care and used geographic targeting to reach the 
poorest areas of the country, particularly the rural 
northeast and north, small cities, and periurban 
neighbourhoods in metropolitan areas. Conditional 
cash transfer programmes evolved into the current 
social protection system (the Bolsa Familia), which now 
beneﬁ ts a quarter of the population. The minimum 
wage increased from US$50 (about R$83 at the 1990 
Progress in terms of MDG indicators Forecast
Eradicate extreme poverty and hunger 
(reduce extreme poverty and 
underweight by half; MDG 1)
Extreme poverty reduced from 8·8% (1990) to 4·2% (2005); underweight prevalence in children 
younger than 5 years reduced from 5·6% (1989) to 2·2% (2006–07)
Extreme poverty reduction goal reached; 
underweight reduction goal achieved
Achieve universal primary education 
(MDG 2)
95% of children and adolescents aged 7–17 years enrolled in school (2008) On track
Promote gender equality and empower 
women (MDG 3)
More girls than boys are enrolled in primary, secondary, and higher education; discrimination 
against women in terms of employment, income, and political representation persists
Gender equality in education goal reached; other 
types of discrimination against women remain
Reduce under-5 mortality by two-thirds 
(MDG 4)
Under-5 mortality falling by 4·8% a year since 1990 (MDG requires annual rate of decline of 4·2%) On track: goal likely to be met in 2011
Reduce maternal mortality by 
three-quarters (MDG 5)
Improved reporting of maternal deaths makes trends diﬃ  cult to estimate but reduction unlikely to 
meet the goal; modelled estimates suggest annual reductions of 4%, lower than the rate of 5·4% 
required to meet the goal
Insuﬃ  cient progress
Combat HIV, AIDS, malaria, tuberculosis, 
and other diseases (MDG 6)
Low prevalence (<0·5%) of HIV, which has been stable since 2000; almost complete eradication of 
some vaccine-preventable diseases (polio, measles, and diphtheria), diarrhoea, and Chagas’ 
disease; partial success in control of malaria, hepatitis A and B, tuberculosis, and schistosomiasis; 
failure to control dengue and visceral leishmaniasis
Striking or partial progress against most 
infectious diseases
MDG=Millennium Development Goal. Data taken from United Nations Development Programme (UNDP) Brazil, the World Bank,6 and previous articles in this Series.1–5
Table 1: Progress in MDGs achieved by Brazil
Population 
(millions)
GDP per head (US$) Gini coeﬃ  cient for 
income concentration
Urbanisation 
(%)
Adult literacy
(%)
Total fertility rate 
(children/woman)
Life expectancy 
at birth (years)
Under-5 mortality 
rate (per 1000)
1960 2008 1960 2008 1984–87 2005–07 1960 2008 1980–82 2007 1960 2009 1960 2009 1960 2009
Brazil 71·7 191·9 1448 4448 0·58 0·55 45 86 75 90 6·2 1·8 54·5 72·7 178 21
Argentina 20·6 40·7 5237 9894 0·45 0·50 74 92 94 98 3·1 2·2 65·2 75·5 72 14
Chile 7·6 16·4 1842 6212 0·56 0·52 68 88 91 97 5·6 1·9 57·0 78·7 139 9
Colombia 16·0 44·9 1130 2986 .. 0·58 45 75 .. 93 6·8 2·4 56·7 73·2 144 19
Mexico 38·6 110·0 2554 6591 0·46 0·48 51 77 83 93 6·8 2·2 57·1 76·5 137 17
Peru 9·9 29·0 1647 2921 0·46 0·50 47 71 82 90 6·9 2·5 47·7 73·5 233 21
Venezuela 7·6 26·4 5425 5964 0·54 0·43 62 93 85 95 6·6 2·5 59·5 74·0 83 18
Mean* .. .. 2973 5761 0·493 0·503 57·6 82·8 86·9 94·1 6·0 2·3 57·2 75·2 134·5 16·2
Diﬀ erence† .. .. –1524 –1314 0·088 0·047 –12·7 2·8 –12·3 –4·1 0·2 –0·5 –2·7 –2·5 43·2 4·4
Ratio‡ .. .. 0·49 0·77 1·18 1·09 0·78 1·03 0·86 0·96 1·04 0·80 0·95 0·97 1·32 1·27
GDP=gross domestic product. *Mean value of the indicator in the six countries (Brazil not included). †Diﬀ erence between Brazil and the mean value of the other six countries. ‡Ratio between Brazil and the mean 
value of the other six countries. Data taken from Gapminder.
Table 2: Evolution of selected demographic, socioeconomic, and health indicators in the seven largest countries in Latin America, 1960–2009
For more on UNDP Brazil see 
http://www.pnud.org.br/odm
For the Gapminder data see 
http://www.gapminder.org/data
Series
2044 www.thelancet.com   Vol 377   June 11, 2011
exchange rate) a month in the 1980s to $300 at present 
(almost R$500), and after a long period of income 
concentration, the Gini coeﬃ  cient started to decline 
from around the year 2000.
In addition to positive changes in social determinants 
of health, Brazil has also proﬁ ted from a strong and 
committed health-sector reform movement, including 
not only academics, policy makers, and managers but 
also health workers from all levels (eg, auxillary staﬀ , 
nurses, and doctors), trade unionists, and the general 
population. This social movement was at the forefront of 
resistance to the post-welfare neoliberal agenda that 
swept through the world in the 1980s and 1990s.1 Even 
when national governments included coalitions led by 
centrist or right-centrist parties, progressive health 
policies continued to be pursued. A comprehensive tax-
based universal health system was created at the same 
time that basic packages and user fees were implemented 
in the public sector in most low-income and middle-
income countries.
Internationally, Brazil adopted an independent and 
outspoken stance in forums such as the World Trade 
Organization, at which unfair drug patent laws were 
challenged.12 At WHO, Brazil expressed strong opposition 
to the year 2000 World Health Report on health systems 
performance. Some people might argue that Brazil’s 
reaction was attributable to its poor ranking among the 
world’s countries, but the critique to that report was 
scientiﬁ cally based, published in a high-impact journal,13 
and later endorsed by the World Health Assembly.14
Nevertheless, progress has been uneven. Here, we 
address some of the main achievements and remaining 
challenges for the health of Brazilian people.
What is special about health in Brazil?
The Uniﬁ ed Health System
Since 1989, all Brazilian people have been entitled to free 
health care at primary, secondary, and tertiary level 
through a national health system that is unique in 
Latin America, being funded by taxes and social 
contributions, such as social security payments.1 As 
described in the ﬁ rst report of this Series,1 implementation 
of the SUS was accompanied by strong decentralisation 
and resulted in increased access to primary health care 
through the Family Health Strategy. This change has led 
to major increases in coverage,1,2 with recorded eﬀ ects on 
infant,15,16 and possibly adult,17 mortality, and reductions 
in unnecessary admissions.18 Brazil has been investing in 
a sustainable system based on primary health care at a 
time when many countries opted for selective primary 
care and for less equitable forms of funding.19 A 2008 
survey showed that 93% of Brazilian people who sought 
health care were able to obtain it,1 and several interventions 
for maternal and child health are now close to reaching 
univer sal coverage, being delivered through the primary 
health-care structure rather than as independent 
vertical programmes.2
Social participation
Intense social participation has been a cornerstone of the 
SUS since the bottom-up movements that resulted in 
Brazilian health-sector reform in the 1970s and 1980s. 
Social participation in health was institutionalised by 
the 1988 constitution and regulated further in 1990 
legislation, establishing national health councils and 
conferences at three levels of government: Brazil has one 
national, 27 state, and more than 5500 municipal health 
councils.1,20 These are permanent bodies in charge of 
formulating health strategies, controlling implementation 
of policies, and analysing health plans and management 
reports submitted by their respective level of government. 
Strong interactions exist between councils, managers, 
and policy makers, forming a complex and innovative 
decision-making process.1 All councils are made up of 
users (50% of members), health workers (25%), and 
health managers and service providers (25%). Health 
conferences are held every 4 years at the three levels, 
which entail many representatives with the same 
proportionate distribution as the councils. The mandate 
of these conferences is to assess the health situation and 
propose directives for health policies, thus contributing to 
inclusion of themes in the public agenda. Among other 
democratic mechanisms, the participatory budget adopted 
by several states and municipalities is quite innovative. A 
proportion of the health budget for a city (municipality) 
or state is deﬁ ned on the basis of popular vote; the 
population of a given city can vote, for example, on 
whether a new intensive-care unit or more health posts 
should be built. Despite these advances, the participatory 
process needs to be improved continuously.21 Social and 
educational diﬀ erences between users, professionals, and 
managers sometimes preclude democratic dialogue on 
equal terms. Corporate interests (see Dangers of 
professional interests) frequently play a part, and techno-
bureaucratic dominance could restrict the ability of 
councils to make substantial changes. As a response to 
these shortcomings, the National Policy for Strategic and 
Participatory Management (known as ParticipaSUS) was 
approved in 2007 with the clear objective to integrate 
actions related to social participation, ombudsmanship, 
auditing, monitoring, and evaluation. Despite some 
diﬃ  culties, institutionalisation of social participation at 
all levels is a unique characteristic of the SUS.22
Human resources for health
Qualiﬁ ed individuals are needed to run this complex 
Brazilian health system. In 2007, 1·7 doctors, 0·9 nurses, 
and 1·2 dentists were available per 1000 population, and 
these people were mostly located in the southeast and 
south of the country.1 Rapid growth has taken place in 
terms of university enrolments for these profes sions: 
in 2008, 90 000 medical, 220 000 nursing, and 
50 000 dentistry students were in training.23 In particular, 
training of nurses has been promoted to address the 
chronic imbalance between nurses and doctors. Even in 
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terms of numbers of doctors, Brazil is outperformed by 
Argentina (3·2 per 1000) and Mexico (2·9 per 1000).24 
The Brazilian ministries of health and education are 
investing heavily to increase the focus of undergraduate 
programmes on primary health care. The latest inno-
vation is undergraduate courses devoted to training of 
public-health (rather than clinical) workers.25 In parallel, 
large programmes were set up to train auxiliary health 
personnel, not only for the primary-care system but also 
for other levels of care. Although health workers already 
represent about 10% of the Brazilian workforce, several 
challenges remain: uneven regional distribution of 
qualiﬁ ed personnel, high turnover, scarcity of structured 
careers, and major diﬀ erences in salaries between 
regions, states, and municipalities, factors which are 
discussed below (see Human resources challenges).1
The public–private mix
Brazil has substantial experience to share with respect to 
public–private partnerships, particularly in terms of 
provision of health services. The interface between the 
two sectors has evolved over time, yet it remains a 
constant source of conﬂ ict and contradictions.1 Many 
private services (non-proﬁ t and for-proﬁ t hospitals, 
diagnostic laboratories, private outpatient clinics, etc) 
provide services for both the SUS and patients with 
private insurance. These facilities sometimes oﬀ er a 
dual standard of care according to how much they are 
being reimbursed per patient. A short visit to most 
private hospitals will show striking diﬀ erences between 
crowded wards occupied by SUS patients and comfortable 
accommodation for those with private insurance. The 
public–private mix also leads to distortions in use of 
procedures, according to how much the government will 
reimburse private providers for a speciﬁ c intervention. 
For example, the sharp rise in number of caesarean 
sections can be traced to higher payments for operative 
than for normal deliveries by social security schemes 
(which predated the SUS) to private providers in 
the 1970s.26 Currently, private providers systematically 
complain that the values they receive from the SUS are 
insuﬃ  cient to provide an adequate standard of care, but 
on the other hand they would not be able to survive 
economically without SUS contributions, which account 
for more than two-thirds of their clientele. Advocates for 
the SUS, in turn, argue that increased coverage and 
funding from the government, coupled with strong 
regulation and auditing, are essential to confer equal 
status to SUS and private patients and for eﬀ ective 
insertion of the private sector into rationalised 
regionalised health-care networks. Public-private inter-
actions are complicated further because many patients 
are entitled to use both systems, and doctors, nurses, 
and other health workers tend to have more than one 
job, typically being employed by both sectors. In short, 
the complex dimensions of the public–private mix in the 
Brazilian health sector are yet to be addressed.
Private health insurance
Important changes are also happening in the private 
insurance sector. Although Brazil has more than 
1000 health plan providers,27 most of these are small and 
operate at local level; among the largest companies with 
national operations, fusions and acquisitions have taken 
place that are rapidly leading to concentration in this 
sector.28 The number of Brazilians with private insurance 
rose by more than 6 million from 2002 to 2008, although 
the proportion of the population covered has remained at 
around 20–25%.1 As many formerly poor families join 
the middle class, the clientele for new mega-companies 
is likely to grow.1 There is concern, however, that the 
overall price of insurance is increasing well above 
inﬂ ation rates, and that new plans exclude disorders for 
which treatment is likely to be costly. Because of the 
universal nature of the SUS, private patients with 
complex conditions that are not covered by their 
insurance plans still rely on the public sector, even 
though their private insurance contributions are largely 
tax-deductible— a highly regressive policy that under-
mines funding for the SUS.29 Although progress has 
been made in regulation of private insurance, a 
redeﬁ nition of the roles of this sector vis-à-vis the SUS is 
essential, and stronger regulation is vital to deﬁ ne how to 
minimise competition between public and private sectors 
and how to reimburse the SUS when patients with 
private insurance use public services.
Capacity building for health research
Scientiﬁ c research is growing rapidly in Brazil.30 The 
National Science and Technology System was launched 
ﬁ ve decades ago with incentives for scientiﬁ c training at 
undergraduate and postgraduate levels. Currently, there 
are 2718 postgraduate courses in the area of health, 
including 55 that oﬀ er masters and doctoral degrees in 
public health and related ﬁ elds.31 Special incentives are 
provided for consolidated programmes, most of which 
are in the southeast and south of the country, to foster 
development of emerging groups in the rest of the 
country. Publications by Brazilian researchers in peer-
reviewed science journals have leapt from 14 237 in 2003 
to 30 415 in 2008.30 2·7% of global scientiﬁ c publications 
in all areas of research are from Brazil, and this proportion 
is advancing faster than comparable countries in public 
health sciences (ﬁ gure). This growth is attributable largely 
to a striking increase in government investment in 
research, including grants and performance-based 
funding of individual researchers and academic depart-
ments, and to investments that ensure open access to 
major Brazilian journals and improve their quality. In 
particular, the ministry of health established, in 2000, its 
department of science and technology, which uses 1·5% 
of the large SUS budget to ﬁ nance health research 
according to a set of priorities32 delineated after a broad 
consultative process. From 2003 to 2009, the depart-
ment ﬁ nanced 3700 projects with a total budget of 
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US$400 million (more than R$907 million at 2009 
exchange rates).33 Funding of postgraduate programmes 
on topics such as surveillance, environmental health, 
hospital management, and technological assessment, 
among many others, is also supported. Academic 
institutions receive funding from the ministry of health 
to oﬀ er these courses regularly to health managers 
employed by the SUS. A major player in this area since 
1979 has been the Brazilian Association of Post-Graduate 
Programmes in Collective Health (ABRASCO), which 
had a major role in creation of the SUS and which now 
represents the academic public health community in 
several national and international forums.34
Mass media and health promotion
Another positive aspect of Brazilian public health is 
heavy involvement of the mass media. Televised soap 
operas are an integral part of Brazilian culture and are a 
major export item to other countries. Since the 1980s, 
serials and other television programmes have been used 
intensively by government and international organisations 
and by civil society to promote healthy behaviours, 
including oral rehydration for diarrhoea, breastfeeding, 
condom use for HIV prevention, and family planning. In 
parallel to the explicit dissemination of health messages, 
the lifestyle portrayed in soap operas—eg, small families35 
and leisure-time physical activity—has contributed to 
shaping behavioural norms. Television and soap operas 
are only one of many media channels used to promote 
healthy behaviours. Local radio stations, usually operated 
by community volunteers, have long had a role in health 
promotion; a good example is the dissemination of 
materials prepared by the Brazilian ministry of health 
and UNICEF during vertical campaigns in the 1980s for 
child-survival interventions. On the negative side, mass 
media has been used heavily to advertise unhealthy foods 
and drinks, aggressively market private insurance, and 
promote high-technology solutions (such as transplants, 
complex diagnostic procedures, caesarean section, plastic 
surgery) as equivalent to the best health care.
Regulation and drugs
A complex system such as the SUS requires a strong 
regulatory body. The National Agency for Health 
Surveillance (ANVISA; the Brazilian equivalent of the 
US Food and Drug Administration) was set up in 1999 as 
an autonomous body to regulate on a broad range of 
matters: medicines and health technologies, environment, 
food, health services, and frontiers.36 Eﬃ  cient action in 
many diﬀ erent areas is proving to be a major challenge, 
as exempliﬁ ed by control of drugs. High treatment 
coverage for key infections such as HIV/AIDS, 
tuberculosis, and leprosy has been achieved, with 
exclusive distribution of free drugs through the SUS on 
the basis of protocols derived through expert consensus. 
Although emergence of strains resistant to antimicrobials 
remains a great concern, levels of primary and secondary 
resistance have been low and stable, suggesting that 
regulation has contributed to rational drug use.3 The 
situation for other antimicrobials is rather diﬀ erent. 
Despite strong regulatory rulings, most antibiotics have 
historically been available to anyone who requested them 
from unlicensed salespersons in private pharmacies;37 
such practices undoubtedly contributed to high levels of 
antimicrobial resistance in patients with community-
acquired urinary infections38 and gonorrhoea.39 At the 
end of 2010, new legislation was passed to prohibit sales 
of antibiotics without a medical prescription, but whether 
it will be enforced eﬀ ectively throughout the country 
remains to be seen.
Commercial advertising
Infant foods, tobacco, alcoholic beverages, and sugared 
soft drinks are examples of products with potential 
harmful eﬀ ects on health that can be controlled through 
legislation. Brazil has a mixed track record in this area. 
Experience with breastmilk substitutes is highly 
positive;2 infant formula and bottles cannot be advertised 
to the general public, and labels of all commercial milk 
products must mention that they are unsuitable to 
replace breastmilk. Marketing techniques—such as 
discounts and gifts—are forbidden in the case of infant 
formula and bottles. Funding of scientiﬁ c meetings by 
infant formula companies is strictly regulated, and 
grants to health personnel are not allowed. The 
International Code of Marketing of Breastmilk 
Substitutes was adopted in 1988 and is enforced strongly 
by the Brazilian ministry of health, in collaboration with 
the International Baby Food Action Network. Marketing 
regulations on tobacco are also comprehensive and 
strict; since 2000, advertising was prohibited, and 
photographs alerting about risks are mandatory on 
cigarette packets.4 By contrast, limits on the marketing 
Figure: Number of scientiﬁ c articles published per year in the area of public health, in selected countries
Data taken from ABRASCO. 
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of alcoholic beverages are weak and are restricted to 
drinks with more than 13% alcohol. This constraint 
allows large marketing campaigns for beer targeted at 
young consumers, including sponsorship of major 
sports and cultural events.4 Regulatory attempts by 
ANVISA have been defeated repeatedly by industry and 
the media. The situation is even more important for 
energy-dense, nutrient-poor processed foods, which are 
not subject to any type of regulation, not even 
advertisements directed at children and adolescents. 
The timid pledges voluntarily assumed in Europe and 
North America by transnational food and beverages 
companies are not honoured in Brazil, and repeated 
attempts by ANVISA to regulate such marketing have 
been blocked by industrial lobbyists.40 Unlike the 
observation for breastmilk substitutes and tobacco, civil 
society move ments have yet to tackle the aggressive 
commercial promotion of alcoholic beverages and 
unhealthy processed foods, possibly because the health 
hazards of moderate alcohol intake and of processed 
foods are less well documented and publicised than are 
those of tobacco or infant formula, both nationally and 
globally. Therefore, unsurprisingly, breastfeeding is on 
the increase2 and smoking is becoming less frequent;4 
by contrast however, no detectable improvements have 
been seen in drinking of alcohol or being overweight.4
Major challenges remain
In a large and complex country such as Brazil, to lay out 
a comprehensive list of challenges to population health—
and in particular, to provision of health care—would be 
overambitious. Nevertheless, some of the most important 
issues that need to be tackled in the near future are 
discussed below. These challenges are by no means the 
only ones. A major need exists to improve coordination 
between the public and private sectors, between diﬀ erent 
government sectors, and between diverse levels of 
government—municipal, state, and federal. Furthermore, 
impact assessment is crucial. Many programmes, 
projects, policies, and other initiatives have been launched 
in the past 20 years, the eﬀ ect of which are unknown 
because of sparse attention to rigorous evaluation.
Reaching the hardest to reach
Despite high overall coverage and narrowing of regional 
and social disparities, important health inequities 
remain. Child mortality rates are still twice as high in 
the north and northeast of Brazil than in the south or 
southeast of the country.2 Indigenous populations, 
mostly in the Amazon region, account for less than 
1% of the population but still lag well behind the rest of 
the country in health indicators.41 Inequalities in ethnic 
groups persist for many indicators, whether in maternal 
and child health, chronic diseases, or violence.2,4,5,42 
Quilombolas—or communities established in the 
19th century by runaway slaves—present unacceptable 
levels of maternal and child health, as do settlements for 
landless families (located throughout Brazil).43 Having 
ensured high levels of access to health services for most 
of the population,1 reduction of social exclusion of 
speciﬁ c subgroups remains a challenge to the SUS. 
Further expansion and consolidation of primary care 
through the Family Health Strategy can help to address 
this challenge, together with the need to increase access 
to secondary and tertiary care.
Financing of the SUS
The SUS has been less successful than originally expected 
with respect to expansion of the share of the public sector 
relative to total health expenditure, which at 41% in 2007 
compares unfavourably to countries with (UK, 82%) or 
without (Mexico, 47%) a national health service.1 
Expenditure in private insurance and out-of-pocket 
payments rose steadily over time, but the SUS has been 
underfunded since its creation, despite speciﬁ c funding 
recommendations embedded in the 1988 constitution. The 
share of the health sector in the federal budget has 
remained stable, and total health expenditure represents 
8·4% of the gross domestic product.44 Important constraints 
exist in infrastructure, supply of specialised services, and 
human resources within the SUS, which have exacerbated 
the dependence of the SUS on purchasing services from 
the private sector, particularly for secondary and tertiary 
care. For example, only a third of all hospital beds used by 
SUS patients are in public hospitals. Private providers, on 
the other hand, are constantly arguing that current levels 
of reimbursement by the SUS barely allow them to meet 
costs. The current ﬁ nancing crisis is a major threat to the 
future of the SUS and a key priority for the future.
Improving quality of care
In this Series, we have not only reported striking 
improvements in access to services and in coverage levels 
for most health interventions but also highlighted that 
the quality of services provided through the SUS is 
sometimes below par—eg, in antenatal care.2 Poor quality 
of care is related to institutional issues, such as high 
turnover of health workers in the Family Health Strategy, 
and diﬃ  culties in attracting skilled doctors to remote 
areas despite high salaries. Such posts are mostly 
attractive to young doctors who come out of medical 
school and choose to postpone their further education, at 
least for a few years. Greater investment in short training 
courses in speciﬁ c areas, such as Integrated Management 
of Childhood Illnesses (IMCI)45 or syndromic man-
agement of sexually transmitted diseases,46 could 
contribute to improvement of quality of care, particularly 
in settings in which laboratory services are limited. Other 
important threats to quality of care include: health-care-
associated acquired infections (a major problem, with 
hospital infection-control programmes being understaﬀ ed 
and without a focus on surveillance); the undue eﬀ ect of 
medical technology on clinical decision making (Brazil 
has one of the highest rates of caesarean section in the 
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world);2 the reduced proportion of services that have 
undergone accreditation (despite introduction of this 
process in the 1990s); and scant continuity of care.47
Human resources challenges
Legislation that regulates hiring of civil servants in Brazil 
is rigid. Workers can only be selected through an open 
competitive process that takes several months, salary 
overheads are substantial, and to dismiss under-performers 
is very diﬃ  cult. For these reasons, doctors, nurses, and 
community health workers are employed by the Family 
Health Strategy through special contracts, which makes 
them much easier to hire and to dismiss and allows 
payment in some categories (such as doctors or nurses) of 
competitive salaries that are well above those received by 
other similarly qualiﬁ ed health workers. This plan also 
allows remote municipalities to oﬀ er high salaries to attract 
professionals who would not otherwise be willing to live in 
such areas. The downside is that family health workers 
have neither a career structure nor job security or fringe 
beneﬁ ts that other civil servants are entitled to. As a result, 
job satisfaction is typically below par and staﬀ  turnover is 
high,48,49 leading to discontinuities in patients’ care.
Dangers of professional interests
Corporatism is a challenge to public health in Brazil. 
Medical societies have lobbied strongly against allowing 
other health workers—even university-trained nurses, 
physiotherapists, or audiologists —to prescribe any type 
of drug, and this action resulted in the Law of Medical Acts 
being passed by congress in 2009. Training of nurses or 
community health workers in the IMCI programme, 
which entails prescription of simple antibiotics to 
children with suspected pneumonia, was interrupted 
in 2002 because of pressure from medical societies, even 
though no doctors are working in 455 of Brazil’s 
5562 municipalities50 and despite strong evidence that 
community case-management can reduce under-5 
mortality51 and that IMCI-trained Brazilian nurses treat 
common illnesses to the same standard as doctors.52 This 
type of corporatism is especially paradoxical in a country 
where, until new legislation was passed in late 2010, 
antibiotics could be purchased easily over the counter. 
Other examples include pressures exerted by doctors 
against allowing nurse-midwives to deliver babies and by 
registered nurses against community health workers 
precluding them from administering injections.
The judiciary and health
Interference of the judicial system in prescription of 
drugs is a unique occurrence in Brazil. The 
1988 constitution states that “health is the duty of the 
state”; patients who have been prescribed expensive, 
sometimes experimental, drugs that are not part of the 
essential drug lists ask judges to issue court orders 
obliging municipal health managers to purchase these 
drugs or to provide elective medical procedures 
immediately. Managers who do not comply are 
threatened with imprisonment. In 2008, the State of 
Rio Grande do Sul spent 22% of its drug budget to 
comply with 19 000 court orders.53 Analysis of injunctions 
in São Paulo city shows that most cases were ﬁ led 
through private attorneys, that 47% of prescriptions were 
by private doctors, and three-quarters of such patients 
lived in high-income neighbourhoods.54 Interference by 
the judiciary violates the key equity principle of the SUS, 
by privileging individuals with higher purchasing power 
and more access to information, boycotting rational 
prescribing practices, and taking resources away from 
priority areas. As a reaction to this stalemate, members 
of parliament are proposing the elaboration of clinical 
guidelines—similar to those issued by the UK’s National 
Institute for Health and Clinical Excellence—to increase 
the powers of health managers in ruling which 
treatments and procedures are cost eﬀ ective.
Reducing dependency on imported health technologies
Augmented demand for public services, combined with 
the rapid process of innovation and adoption of such 
advances in the health system, led to a striking increase in 
the proportion of the national health budget dedicated to 
medical equipment and commodities (drugs, diagnostics, 
vaccines, etc)—from 5·8% in 2003 to 12·3% in 2009. 
These items are mostly imported and represent a growing 
share of the country’s trade balance. The ministries of 
health and of science and technology are making renewed 
Frequency and trends
Health of mothers and children2
Illegal abortions Highly prevalent*
Maternal mortality Slow decline*
Preterm delivery Increasing
Over-medicalisation of childbirth (caesarean sections, etc) Increasing
Infectious diseases3
Dengue fever Repeated epidemics, out of control
Visceral leishmaniasis Increasing
Non-communicable diseases4
Overweight/obesity Rapid increase
Diabetes Increasing
Hypertension High prevalence, still increasing
Psychiatric diseases High prevalence*
Asthma High prevalence*
Cancers of the breast, lung, prostate, and colon Increasing
Tobacco use Declining but still at unacceptable levels
Excessive use of alcohol High prevalence*
External causes5
Homicides Slight decline but still at epidemic levels
Traﬃ  c-related injuries and deaths Slight decline but still at epidemic levels
Domestic violence High prevalence*
*Reliable and representative data for time trends are not available. 
Table 3: Diseases and health problems that need special attention
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investments towards reduction of such dependency, but 
greater eﬀ orts are needed. Brazil’s major investment in 
scientiﬁ c training provides a strong basis for public-private 
partnerships with national entrepre neurs. Mechanisms 
such as tax exemptions, low-interest loans, and market 
guarantees for products produced locally are being trialled, 
and further investments in this area are needed.55,56
Lessening the outcomes of environment and 
climate change
The eﬀ ect of global climate change on disease patterns is 
unquestionable.57 Vast areas of Brazil’s north (Amazon 
rainforest) and centre-west (the Pantanal wetlands and 
savannah) are at especially high risk owing to a 
combination of overexploitation, deforestation, previous 
For a large and complex country undergoing rapid change, a 
call for action towards improvement of health conditions and 
provision of health services must be necessarily long. We have 
divided our recommendations into categories directed at the 
Brazilian Government and at other actors in the health arena. 
The state has a central role in the health sector, but other 
actors must also be involved to achieve the best 
population health.
The Brazilian Government 
We urge the Brazilian Government to reaﬃ  rm its commitment 
to improve the health of all Brazilian people, in particular to 
the 1988 constitution and SUS, by taking action in the 
following areas.
Health conditions
• Expand activities aimed at achieving optimum health for 
all Brazilian people, including health conditions covered 
by the MDGs (health of children and mothers, 
undernutrition, selected infectious diseases including HIV, 
tuberculosis, and malaria) and other major health 
problems (non-communicable diseases and their risk 
factors, remaining infectious diseases, violence, traumas 
and injuries, etc).
• Renew eﬀ orts to further reduce diseases and conditions 
that are still highly prevalent, including traﬃ  c-related 
injuries and deaths, homicides, depression and other 
psychiatric diseases, and use of tobacco, alcohol, and 
illicit drugs.
• Prioritise diseases and conditions that are increasing in 
frequency, including overweight and obesity, diabetes, 
dengue fever, and prematurity, among others.
• Continue to invest in improvement of public health 
surveillance, birth and death information systems 
(particularly for maternal mortality), interpersonal violence, 
and other currently under-reported conditions.
• Enhance actions to further reduce regional, ethnic group, 
and socioeconomic inequalities in health, and particularly to 
reach populations that still have insuﬃ  cient coverage of 
health care, including Indigenous groups, landless peasants, 
and quilombolas (Afro-Brazilian settlements).
• Improve use of health information technology and health 
information systems.
• Ensure that monitoring and evaluation systems take equity 
into account, by producing disaggregated results according to 
socioeconomic status and ethnic origin.
Financing of health care
• Reverse the trend of diminishing participation of public 
funds in total health expenditure by substantially increasing 
the public budget for health and reducing public subsidies 
for the private sector.
• Reduce the dependence of SUS on services purchased from 
the private sector, particularly in-hospital care and 
diagnostic services, by expanding public investment in 
infrastructure.
Primary health care
• Promote and integrate the Family Health Strategy to all 
levels of care as the means for reaching universal coverage 
with health interventions.
• Continue to support programmes in which Brazil currently 
excels, including immunisations, HIV/AIDS, and control of 
endemic diseases such as Chagas disease.
Regulation, accountability, and quality of care
• Promote initiatives to improve quality of care and patients’ 
safety in health care.
• Monitor quality of care at all levels, including systematic and 
regular auditing of deaths and near-misses associated with 
preventable conditions.
• Enforce regulatory measures to avoid distortions and 
over-medicalisation associated with the need to purchase a 
large proportion of services from the private sector and with 
scant performance monitoring of public services.
• Reinforce social participation in the health sector and take 
proactive actions to ensure that existing health councils 
remain representative and able to eﬀ ectively inﬂ uence 
policy at all levels.
• Ensure increased accountability of policy makers, managers, 
and health personnel at all levels by strengthening 
performance measurement and participatory structures, 
and by establishing a strong organisational culture 
orientated around quality and safety.
• Strengthen regulatory bodies to implement eﬀ ective 
certiﬁ cation processes for health workers.
• Expand existing regulations on the advertising of infant 
foods and tobacco, to also cover other potentially unhealthy 
products such as sugared soft drinks and alcoholic beverages.
• Strengthen regulatory bodies to produce measures that are 
more eﬀ ective for protection of the environment and 
workplaces, and for reduction of potential harmful eﬀ ects of 
food and medicines.
(Continues on next page)
Panel: Call for action
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Human resources for health
• Review civil-service regulations to improve the beneﬁ ts and 
working conditions for doctors, nurses, and community 
health workers employed by the Family Health Strategy, to 
avoid turnover and maintain morale.
• Renew eﬀ orts to address health-worker shortages in 
hard-to-reach areas, by expanding on-the-job training and 
promoting task-shifting of procedures from doctors to 
nurses and community health workers.
• Create mechanisms for minimisation of discontinuities in 
the management of SUS at municipal, state, and federal 
levels as a result of political party interests.
Health research
• Continue to expand the funding available for health 
research, with special emphasis on achievement of 
technological independence and on thorough evaluation of 
existing technologies, programmes, and services.
• Consider creating a series of research institutes similar to 
the National Institutes of Health in the USA, or the UK’s 
Medical Research Council.
Intersectoral actions
• Continue to promote conditional cash transfers and real 
increases in the minimum wage, which have contributed 
to income redistribution and near-elimination of 
extreme poverty.
• Enhance social policies and programmes focused on 
education, housing and social security as a means to 
reduce inequities.
Health workers
We urge health workers to:
• Fully engage in the continued process of construction and 
improvement of SUS.
• Participate as key actors in the process of delivering 
high-coverage quality and comprehensive care to the 
whole population.
• Avoid allowing narrow corporate interests to prevent 
essential health interventions from reaching those who 
need them most.
• Collaborate in augmenting access to high quality of care to 
those living in remote areas of the country where doctors 
and nurses are still not accessible.
Private sector
We urge the private sector to:
• Recognise its social role in providing services in coordination 
with SUS when requested, and to fully engage in the pursuit 
of high-quality health care for all Brazilian people.
• Harmonise its own ﬁ nancial requirements with the 
greater goal of achieving the best possible outcome for 
all, by ensuring equal treatment standards to private and 
SUS patients.
• Treat all patients with an equal standard of care, irrespective 
of how services are being reimbursed.
Universities, training institutions, health councils, 
and researchers
We urge universities, training institutions, health councils, and 
researchers to:
• Restate their commitment to SUS, speciﬁ cally, to primary 
health care as gatekeeper of the system and as a means of 
achieving comprehensiveness in care and equity.
• Restate their commitment to train professionals to provide 
high quality of care.
• Review training programmes to ensure a high supply of 
family doctors and specialists directed at the public sector, 
by contrast with the current focus towards production of 
specialists aimed at the private sector.
• Invest further in training of public-health professionals at 
the undergraduate level.
• Ensure that every graduating doctor and nurse has the basic 
skills required to provide high quality of care in the Family 
Health Strategy, independently of whether or not they will 
become specialists in the future.
• Accelerate production of nurses and mid-level health 
workers.
• Increase investment in short in-service courses directed at 
doctors, nurses, and other health workers employed by SUS 
and the Family Health Strategy.
• Continue to undertake research aimed at improvement of 
equity in health, including monitoring and evaluation of 
access and eﬀ ectiveness of health care, patients’ 
satisfaction, cost-eﬀ ectiveness of technologies and 
interventions, development of clinical guidelines, and 
health information technology.
• Expand research eﬀ orts towards achievement of 
technological self-suﬃ  ciency in health products 
(drugs, vaccines, diagnostics, and equipment) and 
health-technology assessments.
• Expand research eﬀ orts to improve knowledge and 
political and public awareness about social determinants 
of health.
Civil society
We urge civil society to:
• Restate its engagement in, and support for, the sanitary 
reform movement and, in particular, SUS and the Family 
Health Strategy.
• Continue to participate in health conferences and councils 
on equal terms with health workers and government 
representatives.
• Help the public sector to improve availability and quality of 
services by denouncing ill-treatment, scant access, and 
under-the-table payment requests.
• Understand that the best health care is not necessarily 
associated with the most advanced technologies.
• Continue to have a key critical and constructive role in 
building a uniﬁ ed, eﬀ ective, and equitable national 
health system.
SUS=Uniﬁ ed Health System. MDG=Millennium Development Goal.
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environmental degradation (eg, mercury poisoning in the 
major Amazon basins because of rustic open-air mining 
activities),58 a local economy that is heavily dependent on 
non-renewable sources of energy (eg, forest chopping and 
burning), and the complex interplay of local and global 
climate changes.59 Progressive environmental degradation 
at the border of pristine forests, new settlements, and 
large urban areas undergoing fast and chaotic development 
has been associated with the urbanisation of malaria.60,61 
In Brazil’s south, repeated severe ﬂ ooding and 
tornadoes—unheard of until recent times—caused major 
material damage and some loss of life together with 
outbreaks of diarrhoea and leptospirosis, which were 
rapidly controlled by the health sector. Although 
attribution of recent increases in dengue fever and 
leishmaniasis to global warming is tempting, more 
complex determinants exist, including disordered 
urbanisation, inadequate sanitation and garbage disposal, 
and deﬁ ciencies in surveillance and control actions.3 The 
social environment is also aﬀ ected by change: widespread 
urbanisation and urban violence5 limit opportunities for 
physical activity in public spaces; increased availability of 
processed foods contributes to being overweight;40 and 
rapid changes in fertility and family structures might lead 
to positive and negative changes in physical and mental 
disease patterns.62 Particular attention should be paid to 
integrated initiatives with several beneﬁ ts—eg, reduction 
in deforestation for production of charcoal with a 
concomitant fall in periurban malaria, or promotion of 
active commuting, which will increase physical activity 
and reduce emissions.63
Tackling problems in health that are on the increase
In this Series, we have highlighted several health 
disorders that are either increasing in prevalence or are 
stable at unacceptably high levels (table 3).1–5 A cross-
cutting issue is the sharp growth in the elderly population,1 
who are at high risk of many of these conditions, 
particularly non-communicable diseases. Health issues 
related to ageing were discussed by Schmidt and 
colleagues.4 Improving the training of doctors and nurses 
employed by the Family Health Strategy in chronic 
conditions is a key challenge.
Concluding remarks
On the basis of present analyses and the preceding 
articles in this Series,1–5 we conclude with a call for action 
(panel), in which we specify challenges directed to the 
government, private sector, academics, health workers, 
and civil society as a whole. We stress, however, that the 
actions recommended and the respective actors involved 
are deeply interconnected, and coordinated action is 
required by all.
Here, we have recorded important improvements in 
health status. The core message from this Series is that 
health improvements can be ascribed to favourable 
changes in social determinants of health, together with a 
strong reform movement dating from the 1970s that led 
Brazil to take the unique approach—as far as Latin 
America is concerned—of creating a national health 
service speciﬁ cally aimed at reduction of inequalities in 
health. Health-sector reform and the resultant creation of 
the SUS were part of a broad movement aimed at 
lowering social exclusion through initiatives in health, 
education, cash transfers, and other sectorial actions.64
Yet, many challenges remain. Despite overall progress, 
socioeconomic and regional disparities remain unaccept-
ably large, reﬂ ecting the fact that much eﬀ ort is still needed 
to improve basic living conditions for much of the 
population. New health issues arise as a result of 
urbanisation and social and environmental change, and 
some old health problems remain unabated. Admin-
istration of a complex, decentralised public health system—
in which a large share of services are contracted to the 
private sector—inevitably causes conﬂ ict and contradiction, 
as does the presence of a strong private health insurance 
sector. The challenge is ultimately political,1 requiring 
continuous engagement by Brazilian society as a whole to 
secure the right to health for all Brazilian people.
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